Exact sciences - Alchetron, The Free Social Encyclopedia
Exact sciences - Alchetron, The Free Social Encyclopedia
2017年8月18日
alchetron.com
Ron Winslow discusses the latest developments in colorectal cancer (CRC) screening and how Exact Sciences is combating the growing screening crisis. On the heels of the USPSTF draft CRC screening guidelines, read more about screening options including Cologuard. https://exas.co/3a2UzM9 Cologuard is intended to screen adults 45 and older at average risk for colorectal cancer. Do not use Cologuard if you have had adenomas, have inflammatory bowel disease and certain hereditary syndromes, or a pers
0:27
Ron Winslow discusses the latest developments in colorectal cancer (CRC) screening and how Exact Sciences is combating the growing screening crisis. On the heels of the USPSTF draft CRC screening guidelines, read more about screening options including Cologuard. https://exas.co/3a2UzM9 Cologuard is intended to screen adults 45 and older at average risk for colorectal cancer. Do not use Cologuard if you have had adenomas, have inflammatory bowel disease and certain hereditary syndromes, or a pers
已浏览 1576 次2021年2月8日
FacebookExact Sciences
On November 8, 2017, Exact Sciences broke ground on a new lab to support the continued growth of Cologuard. See it from the air and ground, and hear about our ongoing work to help more people get screened for colon cancer. | Exact Sciences
1:19
On November 8, 2017, Exact Sciences broke ground on a new lab to support the continued growth of Cologuard. See it from the air and ground, and hear about our ongoing work to help more people get screened for colon cancer. | Exact Sciences
已浏览 2万 次2017年12月13日
FacebookExact Sciences
Exact Sciences | LinkedIn
Exact Sciences | LinkedIn
2024年5月11日
linkedin.com
Newly published research shows that more women with early-stage breast cancer can use a genomic test called the Oncotype DX Breast Recurrence Score® test to help guide their treatment choices with their physician. Do you know how genomic testing works? | Exact Sciences
1:22
Newly published research shows that more women with early-stage breast cancer can use a genomic test called the Oncotype DX Breast Recurrence Score® test to help guide their treatment choices with their physician. Do you know how genomic testing works? | Exact Sciences
已浏览 1317 次2021年12月7日
FacebookExact Sciences
We never cut corners. Advancing earlier detection – the right way – means that we use advanced technology and rigorous science to develop solutions that work. | Exact Sciences
0:44
We never cut corners. Advancing earlier detection – the right way – means that we use advanced technology and rigorous science to develop solutions that work. | Exact Sciences
已浏览 1061 次2019年6月12日
FacebookExact Sciences
The journey to transform cancer care has only just begun. With groundbreaking science, a powerful platform, and key partnerships, we’re reimagining what’s possible for patients and their families. This isn’t just innovation – it’s impact. | Exact Sciences
0:21
The journey to transform cancer care has only just begun. With groundbreaking science, a powerful platform, and key partnerships, we’re reimagining what’s possible for patients and their families. This isn’t just innovation – it’s impact. | Exact Sciences
已浏览 16.8万 次5 个月之前
FacebookExact Sciences
0:28
Exact Sciences Launches the Cancerguard™ Test | Exact Sciences
已浏览 3 次6 个月之前
linkedin.com
0:34
We're proud to be certified as a Great Place To Work® in the U.S. for the seventh consecutive year — and for the first time, we are internationally certified in the UK, Poland, Germany, France, Italy, Japan, and Canada! Shout out to our incredible teams across the globe for their unwavering commitment to creating positive and inclusive workplaces for all. 🔗 http://spr.ly/6186NpBii Great Place To Work | Exact Sciences
已浏览 404 次11 个月之前
FacebookExact Sciences
0:09
This is what makes Exact Sciences great – We are united by our mission to change lives by providing earlier, smarter answers in the cancer journey through advances in cancer detection and clinical decision-making: https://exas.co/40XOIjd | Exact Sciences
已浏览 293 次2023年4月10日
FacebookExact Sciences
0:07
Exact Sciences helps people make informed decisions across the cancer continuum. Our new Oncotype MAP™ test may help connect patients with lung cancer to the right targeted therapies. This Lung Cancer Awareness Month, let’s take on cancer together and raise awareness about this deadly disease: https://exas.co/3nK08TC | Exact Sciences
已浏览 516 次2020年11月23日
FacebookExact Sciences
0:54
It was a busy year at Exact Sciences! As 2024 winds down, join us for a look back at some of our favorite moments: https://www.exactsciences.com/news-events/articles/our-best-of-2024 | Exact Sciences
已浏览 635 次2024年12月30日
FacebookExact Sciences
Exact Sciences stockholders approve acquisition by Abbott
2 个月之前
marketscreener.com
Exact Sciences Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
2 个月之前
marketscreener.com
0:53
Routine screening is key to earlier cancer detection. When cancer is found early, it may be easier to treat. In 2022, get ahead of cancer. Talk to your doctor about screening options that may be right for you. | Exact Sciences
已浏览 1055 次2022年1月27日
FacebookExact Sciences
0:57
See how Cologuard changed these doctors' practices to get patients screened for colon cancer. | Exact Sciences
已浏览 5.2万 次2017年10月16日
FacebookExact Sciences
2:01
Our pipeline is expanding at a rapid rate – starting with promising new biomarkers for the early detection of liver cancer. | Exact Sciences
已浏览 7.1万 次2018年5月31日
FacebookExact Sciences
0:43
Last week, we celebrated the grand opening of our discovery campus lab. The new facility represents how strongly we believe in our community. Together, we are making a difference by helping detect cancer earlier. | Exact Sciences
已浏览 2486 次2019年7月1日
FacebookExact Sciences
0:25
Get screened for colon cancer in just minutes. Watch the story to see how. For average risk adults 50 years and older. Rx Only. See the full story here: https://www.facebook.com/pg/exactsci/videos/?ref=page_internal | Exact Sciences
已浏览 2025 次2017年7月3日
FacebookExact Sciences
0:18
Dr. Angela Nicholas knows first-hand the importance of screening for colorectal cancer - even amidst the COVID-19 pandemic. As a primary care provider, she encourages all her eligible patients 45 and up to use the screening method that is most convenient for them, including noninvasive tests. | Exact Sciences
已浏览 6万 次2021年1月21日
FacebookExact Sciences
3:22
Some patients are resistant to being screened for colon cancer. These doctors weigh in on how offering eligible patients Cologuard, a noninvasive stool-DNA test for average risk adults age 50 and above, helped them encourage more patients to get screened. | Exact Sciences
已浏览 8.5万 次2017年9月11日
FacebookExact Sciences
2:51
“I got screened, and thank goodness I did.” Watch Dorothy’s story and learn more about the importance of colon cancer screening and early detection. | Exact Sciences
已浏览 3.5万 次2017年8月22日
FacebookExact Sciences
0:22
📣 Applications for our summer 2026 internship program are officially open! At Exact Sciences, interns tackle real-world projects that help change lives by bringing fresh energy, ideas, and creativity to our teams. Explore opportunities across the business and be part of work that makes a difference. Apply today: http://spr.ly/6187AoYXx | Exact Sciences
已浏览 1315 次6 个月之前
FacebookExact Sciences
1:42
Breast cancer care has come a long way, and genomic tests like the Oncotype DX Breast Recurrence Score® test have helped transform outcomes for patients. Discover how the Oncotype DX® test helped Katherine–and over 1.8 million others–make more informed treatment decisions: http://spr.ly/6185fB0Jx | Exact Sciences
已浏览 295 次9 个月之前
FacebookExact Sciences
1:54
Nurse practitioners are incredibly influential in patients’ health care decisions. We salute all nurse practitioners for all they do every day to improve the health and well-being of others. Cologuard is intended for adults age 50 at average risk for colon cancer. Rx only. | Exact Sciences
已浏览 9.3万 次2018年4月27日
FacebookExact Sciences
0:16
When it comes to colorectal cancer screening, choosing the right test is crucial to impacting patient health and outcomes. The Cologuard® test offers a highly sensitive, research-backed option that can help improve patient outcomes by detecting colorectal cancer early. Read more: http://spr.ly/61892LvyS | Exact Sciences
已浏览 392 次11 个月之前
FacebookExact Sciences
0:10
We are grateful for the leadership of the patient advocacy community at The Multi-Cancer Early Detection Screening Coverage Act Webinar this week to learn more about the potential of multi-cancer early detection tests to make a meaningful difference for patients. Thrive co-founder Dr. Bert Vogelstein talked about the past, present and hope for the future of cancer screening. | Exact Sciences
已浏览 378 次2021年3月12日
FacebookExact Sciences
0:08
Detecting colorectal cancer early means it is often more treatable. That’s why it’s so important that people know they can start screening at 45 years old. Help us make noise about getting screened by joining our network of Cologuard® patient ambassadors like Yla. | Exact Sciences
已浏览 13.8万 次2024年10月31日
FacebookExact Sciences
0:04
The right tools can help make cancer treatment decisions. A new publication demonstrates the ability of our Oncotype DX Genomic Prostate Score® (GPS™) test to help guide treatment intensity for a larger group of prostate cancer patients. Read more: https://exas.co/3ftKDLh | Exact Sciences
已浏览 174 次2020年6月16日
FacebookExact Sciences
0:06
Our Precision Oncology team is focused on delivering life-changing answers in cancer diagnostics, so patients and health care providers have the information needed to inform improved outcomes. This is especially true with our Oncotype MAP Pan-Cancer Tissue test, which delivers rapid, comprehensive genomic profiling to aid therapy selection for patients with late stage or metastatic cancer. Learn more about the test and how it helps optimize treatments for advanced prostate cancer patients: https
已浏览 266 次2021年2月15日
FacebookExact Sciences
展开